7-PDF_1_nejmoa1214901 (5)

download 7-PDF_1_nejmoa1214901 (5)

of 6

Transcript of 7-PDF_1_nejmoa1214901 (5)

  • 8/12/2019 7-PDF_1_nejmoa1214901 (5)

    1/6

    PROLONGED CO-TRIMOXAZOLE IN HIV-INFECTED CHILDREN

    with a relatively high

    CD T-!ell "er!e#tage

    $%e-&ia#' (() i# the

    ARRO* trial v+, )

    i# the Chil&re# with

    HIV A#ti.i/ti!

    Pr/"hyla0i+ 1CHAP2

    trial34, O5r 6i#&i#g+!/#tra+t with th/+e /6 a

    "revi/5+ /.+ervati/#al

    7,8, +t5&y'(

    whi!h

    +h/we& #/ i#!rea+e&

    ri+9 /6 +evere .a!terial

    i#6e!ti/# a%/#g ART-

    treate& !hil&re# wh/

    +t/""e& re!eiv-i#g !/-

    tri%/0a:/le a6ter g//&

    i%%5#e re!/#+ti-t5ti/#,

    H/wever' +t5&ie+

    i#v/lvi#g a&5lt+ i# A6-ri!a have +h/w# that

    there i+ a# /#g/i#g ri+9

    /6 +evere .a!terial

    i#6e!ti/# a++/!iate&

    with rela-tively high

    CD T-!ell !/5#t+,(;-((

    Mai#tai#i#g

    "r/"hyla0i+ agai#+t a

    wi&e +"e!tr5% /6 gra%-

    "/+itive a#& gra%-

    #egative /rga#i+%+ %ay

    there-6/re .e i%"/rta#t

    i# +5.-8ahara# A6ri!a'

    where rate+ /6 .a!terial

    i#6e!ti/# are high,

    Li9e /ther

    +t5&ie+''3'

    alth/5gh a# e#&-

    "/i#t review !/%-

    %ittee a&?5&i!ate&

    all &iag#/+e+' it i+

    "/++i.le that +/%e

    "arti!i"a#t+ ha&

    t5.er!5l/+i+' P.

    jirove-cii

    "#e5%/#ia' /ri#6e!ti/# &5e t/

    a#/ther /r-ga#i+%'

    a+ "revi/5+ly

    re"/rte&,(

    h/wever' %/+t

    &iag#/+e+ /6

    t5.er!5l/+i+ were

    "re+5%"-tive' the

    #5%.er+ were

    +%all' a#&

    t5.er!5l/+i+ a#&

    .a!terial!/i#6e!ti/# i+ #/t

    5#5+5al,(BK3(,

    2

    ;, A#tiretr/viralthera"y

    6/r HIVi#6e!-

    ti/# i#

    i#6a#t+ a#&

    !hil&re#K

    t/war&+

    5#i-ver+al

    a!!e++

    re!/%%e#

    &ati/#+ 6/r

    a "5.li!

    health

    a""r/a!h,

    Ge#evaK*/rl&

    Health

    Orga#i:ati

    /#' =;;

    $htt"Kww

    w

    ,

    wh/,i#thi

    v"5."ae

    &iatri!i#6

    a#t+=;;

    e#i#&e0,h

    t%l4,

    ,

    G5i&eli#e+/# !/-

    tri%/0a:/l

    e "r/"hy-

    la0i+ 6/r

    HIV-

    relate&

    i#6e!ti/#+

    a%/#g

    !hil&re#'

    a&/le+!e#t+

    a#& a&5lt+

    i# re-

    +/5r!e-

    li%ite&

    +etti#g+K

    re!/%%e#

    &ati/#+ 6/r

    a "5.li!

    health

    a""r/a!h,

    Ge#evaK

    */rl&

    Health

    Orga#i:ati

    /#' =;;

    $htt"K

    www,wh/,i

    #thiv"5.

    "lhiv!t0e

    #4,

    =,7r+!hel 8'

    Ra%/+ '

    Mella&

    / M'

    et al,

    *ith&r

    awal

    /6

    P#e5%

    /!y+ti+

    ?ir/ve!

    ii "r/-

    "hyla0

    i+ i#

    HIV-

    i#6e!te

    &

    !hil&re

    #

    5#&er

    highly

    a!tive

    a#tiret

    r/viral

    thera"

    y,

    AID8

    =;;

    BK=;(

    -,

    (,Na!h

    %a# 8'

    G/#a

    P'

    Da#9

    #er

    *' et

    al,

    The

    rate

    /6

    +eri/

    5+

    .a!te

    rial

    i#6e!t

    i/#+

    a%/#

    g

    HIV-

    i#6e!t

    e&

    !hil&r

    e#

    with

    i%-

    %5#e

    re!/#

    +tit5ti

    /#

    wh/

    have

    &i+!/

    #ti#-

    5e&

    /""/rt

    5#i+ti!

    i#6e!ti

    /#

    "r/"hy

    la0i+,

    Pe&iatr

    i!+

    =;;